LLY

1,095.3

-2.56%↓

JNJ

225.25

-2.39%↓

ABBV

215.55

-1.4%↓

UNH

380.26

-0.52%↓

MRK

119.03

-0.46%↓

LLY

1,095.3

-2.56%↓

JNJ

225.25

-2.39%↓

ABBV

215.55

-1.4%↓

UNH

380.26

-0.52%↓

MRK

119.03

-0.46%↓

LLY

1,095.3

-2.56%↓

JNJ

225.25

-2.39%↓

ABBV

215.55

-1.4%↓

UNH

380.26

-0.52%↓

MRK

119.03

-0.46%↓

LLY

1,095.3

-2.56%↓

JNJ

225.25

-2.39%↓

ABBV

215.55

-1.4%↓

UNH

380.26

-0.52%↓

MRK

119.03

-0.46%↓

LLY

1,095.3

-2.56%↓

JNJ

225.25

-2.39%↓

ABBV

215.55

-1.4%↓

UNH

380.26

-0.52%↓

MRK

119.03

-0.46%↓

Home・Akciju saraksts・Smith & Nephew PLC ADR

Smith & Nephew PLC ADR

Atvērts

29.76 -0.2

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

29.72

Max

30.12

Galvenie mērījumi
By Trading Economics
Ienākumi	35M 331M
Pārdošana	203M 3.2B
P/E Sektora vidējais	21.35 50.102
Dividenžu ienesīgums	2.56
Peļņas marža	10.368
Darbinieki	16,988
EBITDA	133M 856M

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+6.98% upside

Dividendes
By Dow Jones
Dividenžu ienesīgums Sektora vidējais	2.56% 2.33%

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-2.2B 13B
Iepriekšējā atvēršanas cena	29.96
Iepriekšējā slēgšanas cena	29.76

Smith & Nephew PLC ADR Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 28. maijs 22:47 UTC

Peļņas

Costco 3Q Sales Rise as Value Offerings Draw Pressured Consumers -- Update

2026. g. 28. maijs 20:45 UTC

Peļņas

Costco 3Q Profit Rises as Value Offerings Draw Pressured Consumers

2026. g. 28. maijs 23:43 UTC

Tirgus saruna

Nikkei May Rise on Hopes for U.S.-Iran Peace Deal -- Market Talk

2026. g. 28. maijs 23:39 UTC

Tirgus saruna

Gold Edges Lower as Traders Assess Potential U.S.-Iran Deal -- Market Talk

2026. g. 28. maijs 23:31 UTC

Tirgus saruna

KMD Could Realize Value From Selling Either Oboz or Rip Curl -- Market Talk

2026. g. 28. maijs 23:17 UTC

Tirgus saruna

Mainfreight Steering Its Way Out of Tough Period -- Market Talk

2026. g. 28. maijs 23:02 UTC

Tirgus saruna

Costco Has Started Submitting Tariff Refund Claims -- Market Talk

2026. g. 28. maijs 22:41 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 28. maijs 22:41 UTC

Tirgus saruna

MongoDB Still Getting More Growth From Established Customers Than AI -- Market Talk

2026. g. 28. maijs 22:37 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

M&A-Related Insurance Payments In North America Rise -- Market Talk

2026. g. 28. maijs 22:04 UTC

Iegādes, apvienošanās, pārņemšana

CN: Surface Transportation Board Was Right to Freeze the UP-NS Merger and Demand More Info

2026. g. 28. maijs 22:04 UTC

Iegādes, apvienošanās, pārņemšana

CN: This Confirms What CN and Many Stakeholders Have Said All Along, UP and NS Still Have Not Submitted a Credible Case to Support Their Proposed Merger >CNI

2026. g. 28. maijs 21:12 UTC

Peļņas

Iegādes, apvienošanās, pārņemšana

Synopsys Was the Worst S&P 500 Stock Thursday Despite Earnings Beat With AI and Merger in Focus -- Barrons.com

2026. g. 28. maijs 21:00 UTC

Peļņas

Dell Stock Soars on Blowout Earnings. The Outlook Bests Analysts by $20 Billion. -- Barrons.com

2026. g. 28. maijs 20:57 UTC

Peļņas

Dell Stock Soars on Blowout Earnings -- Barrons.com

2026. g. 28. maijs 20:55 UTC

Peļņas

Costco Wholesale Sees a Mixed Quarter, Misses Earnings Estimates -- Barrons.com

2026. g. 28. maijs 20:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 28. maijs 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 28. maijs 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 28. maijs 20:48 UTC

Karstas akcijas

Stocks to Watch Recap: Snowflake, Union Pacific, Hormel Foods -- WSJ

2026. g. 28. maijs 20:34 UTC

Peļņas

One of the S&P 500's Highest Dividends Looks Even Better Now -- Barrons.com

2026. g. 28. maijs 20:31 UTC

Peļņas

Li and XPeng Both Miss Earnings Estimates. One Chinese EV Maker's Stock Is Rising. -- Barrons.com

2026. g. 28. maijs 20:28 UTC

Peļņas

Best Buy's 5% Dividend Yield Looks Even Better After Earnings -- Barrons.com

2026. g. 28. maijs 20:26 UTC

Peļņas

Dell Stock Soars on Blowout Earnings -- Barrons.com

2026. g. 28. maijs 20:20 UTC

Peļņas

Costco 3Q Membership Fees $1.37B

2026. g. 28. maijs 20:20 UTC

Peļņas

Costco 3Q Net Sales $69.15B

2026. g. 28. maijs 20:19 UTC

Peļņas

Costco 3Q Adj Same-Store Sales, Which Excludes Impacts From Gas Prices and Foreign Exchange, Rose 6.6% >COST

2026. g. 28. maijs 20:19 UTC

Peļņas

Costco 3Q Adjusted Digitally-Enabled Sales Rose 20.8% >COST

2026. g. 28. maijs 20:17 UTC

Peļņas

Costco 3Q Digitally-Enabled Sales Rose 21.5% >COST

2026. g. 28. maijs 20:17 UTC

Peļņas

Costco 3Q Same-Store Sales Up 9.8% >COST

Salīdzinājums

Cenas izmaiņa

Smith & Nephew PLC ADR Prognoze

Cenas mērķis

By TipRanks

6.98% augšup

Prognoze 12 mēnešiem

Vidējais 32.32 USD 6.98%

Augstākais 35.11 USD

Zemākais 30 USD

Pamatojoties uz 3 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Smith & Nephew PLC ADR — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

3 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 3 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Smith & Nephew PLC ADR — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.